Friday, July 10, 2026

pharma · Advanced Solid Tumors · Non-Hodgkin's Lymphoma

Liposome Company

Liposome Company trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
21 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Employees
21
Programs
6
Drugs
7
Patents
0
Intelligence · Clinical Trials

Liposome Company clinical trials

Registry index of 6 ClinicalTrials.gov studies linked to Liposome Company programs — each row shows trial ID, program name, phase, status, and indication.

Liposome Company trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

6 updates

Latest clinical program signals indexed for Liposome Company.

  1. Cyclophosphamide Doxorubicin Vincristine Lamivudine — Phase 2

    Clinical update
  2. Lipotecan — Phase 2

    Clinical update
  3. BEL-X-HG — Phase 1

    Clinical update
  4. Ga68-Dolacga Injection — Phase 1

    Clinical update
  5. Lipotecan — Phase 1

    Clinical update
  6. Magnesium Citrate — Unknown

    Clinical update

Trial registry

6 studies